Interesting facts
Interesting Facts about 5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
This compound represents a fascinating intersection of organic chemistry and pharmacology. Its complex structure consists of multiple functional groups, making it a subject of interest for various research applications.
Key Structural Features:
- Diverse Substituents: The presence of methoxy groups contributes to its potential biological activity, enhancing lipophilicity and pharmacological properties.
- Amine Functionality: The methylamino group is crucial for providing basicity, which may influence interactions with biological receptors.
- Alkyl Chain: The isopropyl unit adds steric bulk, which could affect the compound's conformation and reactivity.
In the realm of medicinal chemistry, compounds with such intricate structures are often evaluated for their therapeutic potential. Here are some noteworthy aspects:
Potential Applications:
- Pharmacodynamics: Experience suggests that compounds with similar scaffolds may exhibit activity against certain diseases, potentially including cancer and neurological disorders.
- Optimization of Drug Design: This compound might serve as a lead structure for further investigations aimed at enhancing efficacy and reducing side effects.
- Chemical Synthesis: The synthesis pathway can provide insights into green chemistry practices, depending on the reagents and conditions employed.
As a remarkable example of synthetic organic chemistry, this compound highlights the creativity involved in drug discovery. The insightful phrase “Chemistry is the craft of molecules” encapsulates the essence of understanding and manipulating such intricate substances for beneficial applications. The exploration of this compound in various studies could lead to groundbreaking discoveries in the pharmaceutical realm.
Synonyms
Gallopamil
16662-47-8
methoxyverapamil
5-((3,4-Dimethoxyphenethyl)(methyl)amino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
Galopamilo
Gallopamillum
Galopamilo [INN-Spanish]
Gallopamillum [INN-Latin]
Gallopamil [INN:BAN]
D 600
39WPC8JHR8
Gallopamil (INN)
D600
GALLOPAMIL [MI]
GALLOPAMIL [INN]
(+/-)-Methoxyverapamil
5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
GALLOPAMIL [WHO-DD]
DTXSID5045172
CHEBI:34772
(+/-)-Methoxyverapamil hydrochloride
Methoxyverapamil hydrochloride
5-((3,4-Dimethoxyphenethyl)methylamino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)-
Benzeneacetonitrile, alpha-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-alpha-(1-methylethyl)-
Galopamilo (INN-Spanish)
Gallopamillum (INN-Latin)
5-[(3,4-Dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile
C28H40N2O5
.ALPHA.-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4,5-TRIMETHOXY-.ALPHA.-(1-METHYLETHYL)BENZENEACETONITRILE
.ALPHA.-ISOPROPYL-.ALPHA.-((N-METHYL-N-HOMOVERATRYL)-.GAMMA.-AMINOPROPYL)-3,4,5-TRIMETHOXYPHENYLACETONITRILE
5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
NCGC00015686-05
UNII-39WPC8JHR8
5-(2-(3,4-dimethoxyphenyl)ethyl-methyl-amino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
GALLO?
Lopac0_000778
SCHEMBL49428
BSPBio_001383
KBioGR_000103
KBioSS_000103
CHEMBL51149
DTXCID3025172
BDBM82061
KBio2_000103
KBio2_002671
KBio2_005239
KBio3_000205
KBio3_000206
C08DA02
Bio1_000389
Bio1_000878
Bio1_001367
Bio2_000103
Bio2_000583
HMS1791F05
HMS1989F05
HSCI1_000351
PDSP1_001085
PDSP2_001069
AKOS015914091
CAS_119442
CCG-204863
DB12923
NSC_119442
SDCCGSBI-0050756.P002
IDI1_033853
NCGC00015686-03
NCGC00015686-04
NCGC00015686-06
NCGC00015686-07
NCGC00015686-09
NCGC00015686-10
NCGC00015686-13
NCGC00089760-02
NCGC00089760-03
NCGC00089760-04
NCGC00089760-05
DA-63679
HY-14276
CS-0002968
NS00007539
D08009
Q412127
BRD-A52922642-001-02-9
BRD-A52922642-001-03-7
BRD-A52922642-003-01-7
(+/-)-Methoxyverapamil; Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-a-(1-methylethyl)-; Valeronitrile, 5-[(3,4-dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)- (8CI); a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]met
5-[[2-(3,4-Dimethoxyphenyl)ethyl](methyl)amino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile #
ALPHA-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4,5-TRIMETHOXY-ALPHA-(1-METHYLETHYL)BENZENEACETONITRILE
ALPHA-ISOPROPYL-ALPHA-((N-METHYL-N-HOMOVERATRYL)-GAMMA-AMINOPROPYL)-3,4,5-TRIMETHOXYPHENYLACETONITRILE
Solubility of 5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
The solubility of the compound with the chemical formula C20H24N2O4 can be influenced by several factors, primarily dictated by its molecular structure. This particular compound features a complex arrangement of functional groups, including multiple methoxy (-OCH3) groups, which can affect its interaction with polar and non-polar solvents.
General Solubility Insights
Key aspects of the solubility analysis include:
In practical terms, it is often stated that "the solubility of a compound is a dance between its functional groups and the solvent," emphasizing the need to consider both molecular attributes and environmental conditions when assessing solubility.
Conclusion
In summary, while specific solubility data may not be readily available for this compound, its intricate structure suggests varied solubility depending on the solvent choice. It is advisable to conduct empirical testing to ascertain its solubility characteristics accurately in various solvents.